Cox D A, Cohen M L
Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana 46285, USA.
Pharmacol Rev. 1996 Mar;48(1):3-19.
Oxidized LDL exerts profound effects on the vasomotor response of isolated blood vessels to various stimuli that closely mimic the vascular dysfunction associated with hypercholesterolemia and atherosclerosis in humans. The beneficial effect of lipid-lowering therapy in normalizing vascular function and greatly decreasing the frequency of clinical events associated with atherosclerosis, combined with the ability of antioxidants to alleviate vasomotor disturbances in hypercholesterolemia and slow the progression of atherosclerosis, strongly support a causative role of oxidized LDL in mediating vascular dysfunction in vivo and contributing to the clinical sequalae of coronary artery disease. Further research to understand more fully the mechanisms of oxidized LDL formation and actions in vivo may reveal novel strategies to inhibit these events, and may prove beneficial in the therapeutic management of atherosclerotic disease.
氧化型低密度脂蛋白(Oxidized LDL)对离体血管对各种刺激的血管舒缩反应具有深远影响,这些刺激与人类高胆固醇血症和动脉粥样硬化相关的血管功能障碍极为相似。降脂治疗在使血管功能正常化以及大幅降低与动脉粥样硬化相关的临床事件发生率方面的有益作用,再加上抗氧化剂能够缓解高胆固醇血症中的血管舒缩紊乱并减缓动脉粥样硬化进展,有力地支持了氧化型低密度脂蛋白在介导体内血管功能障碍以及导致冠状动脉疾病临床后果中所起的因果作用。进一步开展研究以更全面地了解氧化型低密度脂蛋白在体内形成和作用的机制,可能会揭示抑制这些事件的新策略,并可能在动脉粥样硬化疾病的治疗管理中证明是有益的。